Question 1

How does Wedelia trilobata work to reduce inflammation?

Accepted Answer

Wedelia trilobata contains active compounds including wedelolactone, luteolin, and kaempferol that demonstrate anti-inflammatory activity through multiple pathways. Wedelolactone inhibits NF-κB signaling and lipoxygenase enzymes, while flavonoids like luteolin reduce pro-inflammatory cytokine production. These compounds work synergistically to modulate inflammatory responses. The sesquiterpene lactones present may also contribute to antipyretic effects by acting on prostaglandin synthesis pathways. Evidence level: C (preclinical studies support these mechanisms, though human clinical trials are limited).

Question 2

Does Wedelia trilobata interact with any medications?

Accepted Answer

Limited research exists on specific drug interactions for Wedelia trilobata. Due to its anti-inflammatory properties, it may theoretically potentiate effects of anticoagulant or antiplatelet medications. Wedelolactone affects certain liver enzymes, suggesting potential for herb-drug interactions with medications metabolized by the cytochrome P450 system. Patients taking blood thinners, NSAIDs, or medications with narrow therapeutic indices should consult a healthcare provider before use. Evidence level: C. More clinical research is needed to establish specific interactions.

Question 3

What is the recommended dosage of Wedelia trilobata?

Accepted Answer

Traditional preparations use 5-10 grams of dried leaf material prepared as a decoction for internal use. For external applications, fresh leaves are crushed into a paste and applied directly to affected skin areas. Standardized commercial preparations are not widely available, so dosing varies based on traditional preparation methods. There are no established clinical dosage guidelines from regulatory authorities. Users should start with lower doses and consult a qualified herbalist. Evidence level: C (based on traditional use).

Question 4

Is Wedelia trilobata safe during pregnancy?

Accepted Answer

Wedelia trilobata is considered unsafe during pregnancy. As a member of the Asteraceae family, it contains compounds that may stimulate uterine contractions or affect fetal development. Traditional use data and preclinical studies suggest potential reproductive toxicity. There is insufficient safety data for breastfeeding, so nursing mothers should also avoid this herb. Pregnant and nursing women should not use Wedelia trilobata. Evidence level: C. Women of reproductive age should use reliable contraception if using this herb therapeutically.

Question 5

What are the traditional uses of Wedelia trilobata?

Accepted Answer

Wedelia trilobata has been used traditionally in tropical regions for treating fever, skin conditions, and wounds. Folk medicine practitioners apply leaf preparations topically for skin infections, rashes, and wound healing. The herb is also used internally as an antipyretic to reduce fever. In some Caribbean and Southeast Asian cultures, it is employed for inflammatory conditions. These uses are supported by ethnobotanical surveys and some preclinical research, but human clinical trials are lacking. Evidence level: C.

Question 6

What are the side effects of Wedelia trilobata?

Accepted Answer

Reported side effects of Wedelia trilobata primarily involve skin sensitization and allergic reactions, particularly with topical application. As an Asteraceae family member, it may cause contact dermatitis in sensitive individuals. Those with known allergies to plants in the daisy family should avoid use. Internal use may cause gastrointestinal upset in some individuals. No serious adverse events have been documented in traditional use literature, but comprehensive safety studies are lacking. Evidence level: C.

Wedelia trilobata

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Synthèse des preuves

Sources PubMed

Sources gouvernementales